Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Accord-UK Ltd (Trading style: Accord), Whiddon Valley, Barnstaple, Devon, EX32 8NS
HYDRALAZINE 25mg TABLETS BP.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Ivory, circular, biconvex film-coated tablets impressed “C” on one face and the identifying letters “HY” on the reverse. |
Each tablet contains 25mg Hydralazine Hydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hydralazine |
Hydralazine is a direct acting vasodilator which exerts its effects principally on the arterioles. Its precise mode of action is not known. |
| List of Excipients |
|---|
|
The tablet core contains: Polyvidone The coating contains: Hypromellose (E464) |
The product containers are rigid injection moulded polypropylene containers and snap-on polyethylene lids.
The product may also be supplied in blister packs and cartons:
a) Carton: Printed carton manufactured from white folding box board.
b) Blister pack: 250µm white rigid PVC. Surface printed 20µm hard temper aluminium foil with 5-6g/M2 PVC and PVdC compatible heat seal lacquer on the reverse side.
Pack sizes: 28s, 30s, 56s, 60s, 84s, 90s, 100s, 112s, 120s, 168s, 180s, 250s, 500s, 1000s.
Polyethylene container with a polypropylene lid.
Pack size: 56s
Accord-UK Ltd (Trading style: Accord), Whiddon Valley, Barnstaple, Devon, EX32 8NS
PL 0142/0499
Date of first authorisation: 6th March 2001
Date of latest renewal: 19th March 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
